Balance Sheet Data
Arcadia Biosciences, Inc. (RKDA)
$3.25
-0.15 (-4.41%)
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
| Total Cash | 21.82 | 25.33 | 25.67 | 28.69 | 20.64 | 228.98 | 571.50 | 1,426.39 | 3,560.05 | 8,885.33 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Cash (%) | ||||||||||
| Account Receivables | 0.17 | 0.60 | 1.41 | 1.37 | 1.29 | 5.65 | 14.09 | 35.17 | 87.78 | 219.08 |
| Account Receivables (%) | ||||||||||
| Inventories | 0.18 | 1.79 | 3.81 | 4.43 | 2.57 | 15.13 | 37.77 | 94.26 | 235.26 | 587.18 |
| Inventories (%) | ||||||||||
| Accounts Payable | 2.65 | 0.49 | 4.11 | 3.64 | 2.88 | 17.71 | 44.21 | 110.35 | 275.41 | 687.38 |
| Accounts Payable (%) | ||||||||||
| Capital Expenditure | -0.25 | -1.48 | -2.33 | -1.01 | -0.07 | -9.35 | -23.33 | -58.22 | -145.31 | -362.67 |
| Capital Expenditure (%) |
To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows)
and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.